Published: Dec 23rd, 2014
Benjamin Keselowsky, Ph.D. recently received a new NIH R01 grant for “Biomaterial Delivery System for Type 1 Diabetes Vaccine”. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases in collaboration with UF Diabetes Institute Director, Mark Atkinson, Ph.D., and Clive Wasserfall, this, $1.5M grant will fund the investigation of biodegradable microparticle/hydrogel formulations delivering immuno-modulatory factors to targeted immune cell types for the prevention and reversal of T1D.
Published: Jun 21st, 2014
UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year’s submissions represent one of the largest showcases of research emanating from UF.
Published: May 29th, 2014
Learn about the latest drug-delivery system developed by University of Florida researches that holds the promise for ways to treat and ultimately prevent persons from developing Type 1 Diabetes. The joint effort is bringing research closer to a cure.
Published: May 20th, 2010
Supported by JDRF at the University of Florida — the Network for Pancreatic Organ Donors with Diabetes (nPOD) program represents the largest consortium dedicated entirely to the study of the […]
Published: May 1st, 2009
Study Name: Immune Function During Various Stages of Insulin Dependent Diabetes Principal Investigator: Mark Atkinson, Ph.D. Study Coordinator: Clive Wasserfall, M.S. Phone: (352) 273-9298 Email: email@example.com What is the Immune Function […]